Searchable abstracts of presentations at key conferences in endocrinology

ea0032p981 | Thyroid (non-cancer) | ECE2013

The influence of single dose recombinant human thyroid-stimulating hormone on the efficacy of radioiodine therapy in patients with non toxic nodular goitre with low RAIU

Abdelrazek Saeid , Mysliwiec Janusz , Szumowski Piotr , Mojsak Malgorzata , Siewko katarzyna , Poplawska-Kita Anna

Aim: The aim of our study was to evaluate the influence of recombinant human thyroid-stimulating hormone (rhTSH) on the efficacy of radioiodine therapy in patients with non toxic nodular goitre with low RAIU.Materials and methods: The study was performed on 50 patients with non toxic nodular goitre (36 females and 14 males, aged 34–75 years) referred for radioiodine therapy. All patients had low RAIU (8–16%), 24 h after a diagnostic dose of I-1...

ea0030p4 | (1) | BSPED2012

The management of 21-hydroxylase deficiency: a retrospective audit in south east and west of Scotland

Chetty Tarini , Bischof-Renner Andrea , Bath Louise

Introduction: The management of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase (21-OH) deficiency is challenging and clinical practice is known to vary. Clinical guidelines were published in the Consensus Statement in 2002 encompassing evidence for best practice.Aims: To compare the management of paediatric patients with severe 21-OH deficiency in South East and West of Scotland (SE and WoS) with consensus guidelines. To determine the nature ...

ea0030p27 | (1) | BSPED2012

Cerebral oedema in toddlers; risks and challenges: a case series

Sundaram Manu , Ayuk Loveline , Parakkal Raffeeq

Prevention, diagnosing, and adequate management of cerebral oedema in diabetic ketoacidosis are of vital importance. This can be very challenging in infants and toddlers as symptoms can be very subtle or difficult to interpret. Young age, new diagnosis of diabetes, and severe acidosis at presentation has been reported as risk factors for the development of cerebral oedema. We report our experience in managing one infant and two toddlers newly diagnosed diabetics who were refer...

ea0029p1598 | Thyroid (non-cancer) | ICEECE2012

The influence of recombinant human thyroid stimulating hormone (rhTSH) on the efficacy of radioiodine therapy in patients with toxic nodular goitre with low RAIU

Abdelrazek S. , Rogowski F. , Szumowski P. , Daniluk M. , Winska M. , Szorc M.

The aim of our study was to evaluate the influence of rhTSH on the efficacy of radioiodine therapy (RIT) in patients with toxic nodular goitre(TNG) with low RAIU. Materials and methods: The study was performed on 30 patients with TNG (22 female and 8 male aged 45–78years) referred for 131I therapy. All patients had low RAIU (16–18%) 24 hours after a diagnostic dose of I-131 (4 MBq). All the patients received a single intramuscular dose of 0.05 mg rhTSH (thyrogen). 24...

ea0029p1601 | Thyroid (non-cancer) | ICEECE2012

The effect of radioiodine therapy in 950 patients with subclinical hyperthyroidism

Abdelrazek S. , Rogowski F. , Szelachowska M. , Mojsak M. , Kraszynska A. , Kornas M. , Gorska M.

The aim of our study was to assess the influence of radioiodine (131I) therapy on the achievement of euthyroidism, prevention of adverse effects on the cardiovascular and prevent evolvement to overt hyperthyroidism. Material and methods: We treated 950 patients, aged 30–70 years; 87% of them were female and 13% male; 320 patients with multinodular goitre (MNG), and 630 patients with autonomous nodule (ATN). Some of the patients were treated with antithyroid drugs for 1 to...

ea0029p1730 | Thyroid (non-cancer) | ICEECE2012

Quality of life of patients after surgical treatment of Graves' disease by catamnesis data

Dreval A. , Nechaeva O. , Mamedova T. , Shestakova T. , Chikh I. , Komerdous I.

Materials and methods: The study included 58 patients (50 female, 8 males) aged from 38 to 60 years, have received surgical treatment for GD with the period of follow-up after treatment for 2 to 10 years. The patients were divided into 2 groups depending on the initial level of TSH. In the first group (33 persons) included patients with low-normal level of TSH (0.4–2.5 mU/ml), the in second group (25 persons) with upper-normal level of TSH (2.6–4.0 mU/ml). Quality of...

ea0028p60 | Clinical practice/governance and case reports | SFEBES2012

Case Report: Postoperative hypocalcaemia, a novel management option

Zhyzhneuskaya Sviatlana , Chapman John , Carey Peter , Nayar Rahul , Pearce Simon

Postoperative hypocalcaemia is usually transient; we present a case report of persistent symptomatic hypocalcaemia following elective thyroid surgery; its challenging pharmaceutical management including the successful use of a novel therapeutic agent. A 56 yr old woman with known type 2 diabetes, morbid obesity (treated with gastric band), and benign intracranial hypertension underwent total thyroidectomy for a multi-nodular goitre, following which she became symptomatic with ...

ea0026p71 | Endocrine tumours and neoplasia | ECE2011

Comparison of the efficacy and the tolerance of high-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls

Colombo C , Verga U , Perrino M , Vicentini L , Beck-Peccoz P , Fugazzola L

The recent unavailability of pentagastrin (Pg) in several European Countries, prompted us to evaluate the potency and tolerability of the ‘high dose calcium test’ (Ca) in the stimulation of serum human calcitonin (hCt). We compared Pg- and Ca-stimulated hCt in 19 patients already treated for medullary thyroid cancer (MTC) in remission (n=19) or in persistence (n=13), in 18 patients with chronic thyroiditis and multinodular goiter, and in 15 healthy cont...

ea0026p407 | Thyroid (non cancer) | ECE2011

The outcome of radioiodine therapy after 10 years in patient with toxic nodular goiter

Abdelrazek Saeid , Rogowski Franciszek , Szumowski Piotr , Szorc Malgorzata , Gorska Maria , Szelachowska Malgorzata

We treated 4150 patients, aged 30–70 years; 1950 patient with toxic multinodular goitre (TMNG), and 2200 patient with autonomous toxic nodule (ATN). Qualification of these patients was based on high levels of serum fT3 and fT4, low levels of serum TSH. Malignant changes were excluded in all nodules by fine needle aspiration biopsy. All the patients had serum TSH levels ≤0.1 mU/l and the effective T-half was ≥3 days at the time of treatmen...

ea0026p658 | Developmental endocrinology | ECE2011

Disorders of sex development: current scenario in North East India

Saikia U K , Choudhury S D

Introduction: The understanding and approach to management of DSDs has undergone rapid changes in recent years with focus on early diagnosis followed by disclosure and decision making with family members. However in certain regions specially in developing countries, lack of awareness and the social environment contribute to late diagnosis and problems in management. The present study was done to assess the clinical presentation of DSDs attending an endocrine clinic at a tertia...